Pefloxacin in the treatment of septicaemia: three years' experience

Area of Science:

• Clinical Medicine
• Infectious Diseases
• Pharmacology

Background:

• Septicaemia remains a significant cause of morbidity and mortality.
• Peffloxacin is a fluoroquinolone antibiotic with broad-spectrum activity.
• Evaluating antibiotic efficacy in complex infections is crucial for treatment guidelines.

Purpose of the Study:

• To retrospectively analyze the treatment outcomes of septicaemia cases managed with pefloxacin.
• To assess the efficacy of pefloxacin monotherapy versus combination therapy.
• To identify factors associated with treatment success or failure in septicaemia.

Main Methods:

• Retrospective analysis of 60 consecutive septicaemia cases.
• Treatment groups included pefloxacin alone (30 cases) and pefloxacin in combination with other antibiotics (30 cases).
• Outcomes were evaluated based on satisfactory treatment response, failures, and relapses.

Main Results:

• Peffloxacin achieved a satisfactory outcome in 87% of 38 evaluable Gram-negative septicaemias.
• Success rates for Gram-negative septicaemia were 25 of 29 cases treated with pefloxacin alone.
• Fifteen of 21 staphylococcal septicaemias had satisfactory outcomes, primarily with combination therapy.

Conclusions:

• Peffloxacin is an effective treatment option for Gram-negative septicaemia, including when used as monotherapy.
• Combination antibiotic therapy including pefloxacin shows promise for staphylococcal septicaemia.
• Underlying patient conditions significantly influence treatment outcomes in septicaemia.